Evidence map›Paper›PMID 33534821›Full record

ArticlePloS one2021

Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy.

Juha W Koskenvuo, Inka Saarinen, Saija Ahonen, Johanna Tommiska, Sini Weckström, Eija H Seppälä, Sari Tuupanen, Tiia Kangas-Kontio, Jennifer Schleit, Krista Heliö and 14 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 3 countries.

Juha W KoskenvuoBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.ORCID 0000-0002-2306-2883
Inka SaarinenBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Saija AhonenBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Johanna TommiskaBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Sini WeckströmHeart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Eija H SeppäläBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Sari TuupanenBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Tiia Kangas-KontioBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Jennifer SchleitBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Krista HeliöBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Julie HathawayBlueprint Genetics Inc, a Quest Diagnostics Company, Seattle, Washington, United States of America.ORCID 0000-0002-0144-4653
Anders GummessonDepartment of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0003-0024-960X
Pia DahlbergDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Tiina H OjalaDepartment of Pediatric Cardiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Ville VepsäläinenHeart Center, Kuopio University Hospital, Kuopio, Finland.
Ville KytöläBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Mikko MuonaBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Johanna SistonenBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Pertteli SalmenperäBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Massimiliano GentileBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Jussi PaananenBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Samuel MyllykangasBlueprint Genetics, a Quest Diagnostics Company, Espoo, Finland.
Tero-Pekka AlastaloBlueprint Genetics Inc, a Quest Diagnostics Company, Seattle, Washington, United States of America.
Tiina HeliöHeart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Blueprint Genetics (Finland) · FIUniversity of Helsinki · FIQuest Diagnostics (United States) · USSahlgrenska University Hospital · SEKuopio University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFamilial dilated cardiomyopathy (DCM) is typically a monogenic disorder with dominant inheritance. Although over 40 genes have been linked to DCM, more than half of the patients undergoing comprehensive genetic testing are left without molecular diagnosis. Recently, biallelic protein-truncating variants (PTVs) in the nebulin-related anchoring protein gene (NRAP) were identified in a few patients with sporadic DCM. METHODS AND

resultsWe determined the frequency of rare NRAP variants in a cohort of DCM patients and control patients to further evaluate role of this gene in cardiomyopathies. A retrospective analysis of our internal variant database consisting of 31,639 individuals who underwent genetic testing (either panel or direct exome sequencing) was performed. The DCM group included 577 patients with either a confirmed or suspected DCM diagnosis. A control cohort of 31,062 individuals, including 25,912 individuals with non-cardiac (control group) and 5,150 with non-DCM cardiac indications (Non-DCM cardiac group). Biallelic (n = 6) or two (n = 5) NRAP variants (two PTVs or PTV+missense) were identified in 11 unrelated probands with DCM (1.9%) but none of the controls. None of the 11 probands had an alternative molecular diagnosis. Family member testing supports co-segregation. Biallelic or potentially biallelic NRAP variants were enriched in DCM vs. controls (OR 1052, p<0.0001). Based on the frequency of NRAP PTVs in the gnomAD reference population, and predicting full penetrance, biallelic NRAP variants could explain 0.25%-2.46% of all DCM cases.

conclusionLoss-of-function in NRAP is a cause for autosomal recessive dilated cardiomyopathy, supporting its inclusion in comprehensive genetic testing.

Indexed as

Cardiomyopathy, DilatedAdultChild, PreschoolFemaleGenetic TestingHumansLoss of Function MutationMaleMiddle AgedMuscle ProteinsRetrospective StudiesYoung AdultMuscle ProteinsNRAP protein, human

Identifiers

PMID33534821
PMCPMC7857588
OpenAlexW3127581707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.